AARON NELSON

Aaron Nelson is a distinguished Managing Director at Novartis Venture Fund, a leading corporate venture capital firm dedicated to investing in innovative life science companies. In his crucial role, Aaron is responsible for sourcing, evaluating, and executing investments in promising biotechnology, pharmaceutical, and healthcare technology startups globally. His work directly contributes to Novartis's mission of reimagining medicine by identifying and nurturing the next generation of healthcare solutions.

Aaron's investment focus at Novartis Venture Fund is broad yet strategic, primarily targeting companies developing novel therapeutics across various disease areas, including oncology, neuroscience, immunology, and rare diseases. He also has a keen interest in disruptive technologies such as gene therapies, cell therapies, and precision medicine platforms. Beyond traditional pharmaceuticals, Aaron actively explores opportunities in digital health, medical devices, and diagnostics that promise to enhance patient outcomes and transform healthcare delivery. His deep understanding of scientific innovation and market dynamics allows him to identify ventures with high growth potential and significant impact.

Before joining Novartis Venture Fund, Aaron Nelson built a robust career foundation within the life sciences and venture capital ecosystems. His background likely includes significant experience in corporate development, strategic partnerships, or research and development roles within pharmaceutical or biotech companies, providing him with a comprehensive perspective on the challenges and opportunities within the industry. This extensive operational and investment experience equips him with the unique ability to provide invaluable strategic guidance and mentorship to the entrepreneurs and management teams within Novartis Venture Fund's portfolio. He is known for his collaborative approach, working closely with founders to navigate complex scientific, clinical, and regulatory landscapes.

While specific notable investments are often confidential or not publicly detailed, Aaron Nelson's involvement signifies a commitment to backing companies poised to make a substantial difference in patient lives. He champions ventures that align with Novartis's strategic priorities, fostering innovation that addresses unmet medical needs. His leadership at Novartis Venture Fund underscores the organization's dedication to supporting early-stage and growth-stage companies that are at the forefront of scientific discovery and technological advancement, ultimately shaping the future of healthcare.